These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Independent regulation of activation and inactivation phases in non-contractile Ca2+ transients by nicotinic receptor at the mouse neuromuscular junction.
    Author: Tsuneki H, Kimura I, Kimura M.
    Journal: Brain Res; 1994 Jul 11; 650(2):299-304. PubMed ID: 7953695.
    Abstract:
    Non-contractile Ca2+ mobilization (not accompanied by muscle contraction) occurs by the prolonged activation of nicotinic acetylcholine receptor in mouse diaphragm muscles treated with anticholinesterase. To elucidate the regulation properties of non-contractile Ca2+ mobilization by nicotinic receptor, the modes of action of competitive and depolarizing neuromuscular blockers were investigated. (+)-Tubocurarine (0.07-0.1 microM), pancuronium (0.05 microM) and alpha-bungarotoxin (0.03-0.06 microM) decreased decay time (T2, duration of inactivation phase) without changes in rise time (T1, duration of activation phase) of non-contractile Ca2+ transients. These competitive antagonists also suppressed their peak amplitude at higher concentrations than those affecting T2. Contractile Ca2+ transients were not inhibited by these antagonists at the concentrations used. Decamethonium (1 microM), a depolarizing blocker, suppressed the peak amplitude of non-contractile Ca2+ transients without affecting their duration. In contrast, succinylcholine (0.3 microM) suppressed both peak amplitude and T1 without changing T2, presumably via the receptor desensitization. Succinylcholine but not decamethonium inhibited contractile Ca2+ transients at the concentrations used. These results demonstrate that the activation and inactivation phases in non-contractile Ca2+ transients are independently regulated by nicotinic acetylcholine receptor.
    [Abstract] [Full Text] [Related] [New Search]